JapanPart of Teijinteijin-regenet.com
None yet. When a new project in the record names Teijin Regenet as owner, partner or investor, it shows here.
Signed a Sept 25, 2026 agreement to join a global CDMO alliance for cell and gene therapy, aiming to expand manufacturing support, quality tools and cross-region collaboration.
Joint research will advance manufacturing, automation and quality-control for cell and gene therapies to expand Japan's manufacturing infrastructure and patient access.
